These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6905267)

  • 21. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease.
    Saito H; Poon MC; Vicic W; Goldsmith GH; Menitove JE
    J Lab Clin Med; 1978 Jul; 92(1):84-95. PubMed ID: 659966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prekallikrein and plasminogen proactivator: absence of plasminogen proactivator in Fletcher factor deficient plasma.
    Venneröd AM; Laake K
    Thromb Res; 1976 Apr; 8(4):519-22. PubMed ID: 1273811
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of hypertension and its complications in congenital prekallikrein deficiency: analysis of all reported cases and clinical significance.
    Girolami A; Ferrari S; Cosi E; Sambado L; Girolami B
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):560-3. PubMed ID: 25886833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fletcher factor deficiency with mildly prolonged activated PTT.
    Saade M
    South Med J; 1980 Jul; 73(7):958. PubMed ID: 6901278
    [No Abstract]   [Full Text] [Related]  

  • 25. Prekallikrein deficiency in a 15-year-old boy with Ménière's disease: a case report.
    Criel M; Declau F; Schuermans C; Ver Elst K; Vermeiren S; Weekx S; Lemmens J
    Acta Clin Belg; 2017 Aug; 72(4):274-277. PubMed ID: 27615147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.
    Donaldson VH; Kleniewski J; Saito H; Sayed JK
    J Clin Invest; 1977 Sep; 60(3):571-83. PubMed ID: 893663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis].
    Marongiu F; Mamusa AM; Solinas A; Demelia L; Mulas G; Perpignano G
    Haematologica; 1982; 67(6):926-30. PubMed ID: 6819198
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA typing in a new family with Fletcher factor deficiency.
    Raffoux C; Alexandre P; Perrier P; Briquel ME; Streiff F
    Hum Genet; 1982; 60(1):71-3. PubMed ID: 6918357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory suggestions: Improving the sensitivity of the Fletcher factor assay.
    Sibley C; Evatt BL
    Am J Clin Pathol; 1979 May; 71(5):570-3. PubMed ID: 453074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA; Sculley PW; Green EM; Johnson GS
    Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports.
    Girolami A; Rolland C; Sexton D; Vardi M; Bernstein JA
    Allergy Asthma Proc; 2020 Jan; 41(1):10-18. PubMed ID: 31888778
    [No Abstract]   [Full Text] [Related]  

  • 35. The absence of release of the plasminogen activator after venous occlusion in a Fletcher trait patient.
    Estelles A; Aznar J; España F
    Thromb Haemost; 1983 Feb; 49(1):66. PubMed ID: 6552103
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete prekallikrein deficiency masquerading as a lupus anticoagulant.
    Moore GW; Sangle SR; Archer RA; Maloney JC; Rahman A; D'Cruz DP
    Thromb Res; 2014 Feb; 133(2):301-2. PubMed ID: 24315318
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of bovine plasma prekallikrein (Fletcher factor).
    Heimark RL; Davie EW
    Biochemistry; 1979 Dec; 18(25):5743-50. PubMed ID: 518867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of Hageman factor deficiency with myeloid leukaemia.
    McGrath K; Koutts J
    Aust N Z J Med; 1975 Apr; 5(2):155-7. PubMed ID: 1057927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.